Paris, France

Stéphanie Graff-Dubois

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about inventor Stéphanie Graff-Dubois, who stands as a beacon of innovation in Paris, FR, inspiring the next generation of inventors to push the boundaries of what is possible and create a better world for tomorrow.

Title:

Stéphanie Graff-Dubois: Pioneering Innovation in Immunotherapy and Anticancer Therapy

Introduction:

Stéphanie Graff-Dubois, a visionary inventor based in Paris, FR, has made significant contributions to the fields of immunotherapy and anticancer therapy. His inventive spirit and groundbreaking work have been instrumental in shaping the future of healthcare and treatment modalities.

Latest Patents:

Stéphanie Graff-Dubois holds two noteworthy patents that have revolutionized the landscape of immunotherapy and anticancer therapy. One of his latest patents involves the identification, optimization, and use of cryptic HLA-B7 epitopes for immunotherapy. This innovative method enhances the immunogenicity of cryptic epitopes, stimulating an immune reaction against these epitopes in patients with a specific HLA-B* phenotype. His second patent focuses on polynucleotides encoding MHC class I-restricted hTERT epitopes, offering novel possibilities in cancer treatment and prevention.

Career Highlights:

Throughout his illustrious career, Stéphanie Graff-Dubois has made significant strides in the field of biomedical research. He has been associated with prestigious institutions such as Institut Pasteur and Inserm, where his pioneering work has garnered international acclaim. His dedication to advancing immunotherapy and anticancer therapy has set new benchmarks in the industry.

Collaborations:

Stéphanie Graff-Dubois has collaborated closely with esteemed colleagues such as Jeanne Menez-Jamet and Pierre Langlade-Demoyen. Together, they have synergized their expertise to develop innovative solutions aimed at revolutionizing the treatment of cancer and enhancing the efficacy of immunotherapy.

Conclusion:

In conclusion, Stéphanie Graff-Dubois stands out as a trailblazing inventor whose visionary work has left an indelible mark on the fields of immunotherapy and anticancer therapy. His patents reflect his commitment to innovation and his relentless pursuit of excellence in healthcare. As a beacon of inspiration for aspiring inventors, Stéphanie Graff-Dubois continues to shape the future of medical science and pave the way for a brighter tomorrow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…